FDA panel: Moderna's COVID vaccine effectively prevents severe cases of COVID
On Tuesday, Dec. 15 a committee of federal health officials with the U.S. Food and Drug Administration announced their findings in relation to the effectiveness of Moderna's coronavirus vaccine, calling it highly protective for adults and effective in preventing severe cases of COVID-19.
With this news, the agency is likely to officially grant emergency authorization for a second coronavirus vaccine this week for millions of Americans.
The positive news comes as hospitals across the nation received shipments of Pfizer's COVID vaccine and ramped up inoculation efforts.
Pfizer and BioNTech's vaccine was cleared by the FDA last week.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
Max Johnson in the mix for LSU starting quarterback job
Coach O admits to mistakes, takes steps to correct them in the...
Saints QB Jameis Winston gets emotional discussing Drew Brees
Southern football on the road to play Texas Southern
Javonte Smart's impact on the Baton Rouge community